Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-174-2 | CAS number: 79-07-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: other routes
Administrative data
- Endpoint:
- acute toxicity: other routes
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Only limited details were available from literature, therefore these data are considered relevant, but less adequate and reliable for classification.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1979
Materials and methods
- Principles of method if other than guideline:
- other: not specified
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- 2-chloroacetamide
- EC Number:
- 201-174-2
- EC Name:
- 2-chloroacetamide
- Cas Number:
- 79-07-2
- Molecular formula:
- C2H4ClNO
- IUPAC Name:
- 2-chloroacetamide
- Details on test material:
- No data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 180-200g
- Fasting period before study: In some experiments rats fasted overnight were used
- Diet: Standard laboratory rat diet (Astra-Ewos, R3, with a vitamin E content of 20 mg/kg), ad libitum
- Water: Ad libitum
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- physiological saline
- Details on exposure:
- Chloroacetamide was administered intraperitoneally as a single dose.
- Doses:
- 75 mg/kg bw
- No. of animals per sex per dose:
- 3 - 5 rats
- Control animals:
- yes
- Details on study design:
- The treatment was administered between 8 and 10 AM.
The rats were killed by decapitation and the liver immediately perfused in situ with ice-cold 0.9% NaCI solution
and homogenized in 9 vol of ice-cold 0.15 M KCL. Aliquots of whole homogenate were deproteinized with
1% H3PO4 and 0.6% thiobarbituric acid (TBA) added. The mixture was then heated for 45 min in a boiling water
bath. After cooling TBAreactive material was extracted with n-butanol, and the absorbance at 535 nm of the
organic phase (=TBA value) was determined (Uchiyama and Mihara, 1978).
Hepatic glutathione (GSH) was measured as low molecular weight thiols (Saville, 1958). - Statistics:
- from 3-5 rats, mean TBA-values +- SD were plotted vs hours after treatment
Results and discussion
Effect levels
- Dose descriptor:
- other: Hepatotoxicity
- Effect level:
- 75 mg/kg bw
- Mortality:
- 112.5 mg/kg bw chloroacetamide resulted in a high mortality within 5-6 hrs.
- Clinical signs:
- A single dosage of 37.5 mg/kg bw had no apparent effect on TBA values or liver morphology.
75 mg/kg bw was nonlethal but induced morphological and biochemical changes. - Gross pathology:
- Livers from rats treated with 75 mg/kg usually showed swelling, hydropic degeneration, and single , necrotic hepatocytes.
These alterations appeared to be accentuated in the peripheral and midzonal areas after 6 and 8 hr.
After the high dose (112.5 mglkg bw), three of four of these rats died after 4-5 hr. They exhibited fatty degeneration and extensive necrosis of the centrilobular areas accompanied by leucocytic infiltration. In the periphery of the lobu!e there was pronounced capillary congestion with hemorrhages and disruption of the normal lobular architecture. - Other findings:
- 3-6 h p.a.: Lesions in the liver parenchyma and enhancement of lipid peroxidation. 24-48 h p.a.: Reversible morphological changes notably hydropic degenerations. GSH content decreased rapidly. 1 h p.a. GSH increased and was slightly higher than normal at 48 and 72 h p.a.. The authors conclude that GSH depletion leads to lipid peroxidation without permanent damage of hepatocytes.
Applicant's summary and conclusion
- Conclusions:
- The authors’ suggestion that compartmentalization applies to peripheral cells only is supported by the observation
that GSH concentrations are lower in the center than in the periphery of the lobule. (Smith et al. 1979).
The reversible nature of the peripheral lesion indicates that cells in this area have a considerable capacity to
withstand lipid peroxidation. - Executive summary:
Intraperitoneal administration in rats of 75 mg/kg bw Chloroacetamide indicates that hepatic GSH depletion leads to lipid peroxidation, which can be significantly increased without causing permanent damage to hepatocytes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.